These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23823008)

  • 21. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.
    Javitt DC; Zukin SR; Heresco-Levy U; Umbricht D
    Schizophr Bull; 2012 Sep; 38(5):958-66. PubMed ID: 22987851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice.
    Zhou X; Qyang Y; Kelsoe JR; Masliah E; Geyer MA
    Genes Brain Behav; 2007 Apr; 6(3):269-76. PubMed ID: 16899055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus.
    Zhang Y; Yoshida T; Katz DB; Lisman JE
    J Neurophysiol; 2012 Jun; 107(11):3181-9. PubMed ID: 22423006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia.
    Kittelberger K; Hur EE; Sazegar S; Keshavan V; Kocsis B
    Brain Struct Funct; 2012 Apr; 217(2):395-409. PubMed ID: 21979451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia.
    Grent-'t-Jong T; Rivolta D; Gross J; Gajwani R; Lawrie SM; Schwannauer M; Heidegger T; Wibral M; Singer W; Sauer A; Scheller B; Uhlhaas PJ
    Brain; 2018 Aug; 141(8):2511-2526. PubMed ID: 30020423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.
    Labrie V; Lipina T; Roder JC
    Psychopharmacology (Berl); 2008 Oct; 200(2):217-30. PubMed ID: 18597079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMDARs Containing NR2B Subunit Do Not Contribute to the LTP Form of Hippocampal Plasticity: In Vivo Pharmacological Evidence in Rats.
    Ahnaou A; Heleven K; Biermans R; Manyakov NV; Drinkenburg WH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.
    Halene TB; Ehrlichman RS; Liang Y; Christian EP; Jonak GJ; Gur TL; Blendy JA; Dow HC; Brodkin ES; Schneider F; Gur RC; Siegel SJ
    Genes Brain Behav; 2009 Oct; 8(7):661-75. PubMed ID: 19563516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Dysregulations in CA1 Hippocampal Networks of a 3-Hit Mouse Model of Schizophrenia.
    Percelay S; Billard JM; Freret T; Andrieux A; Boulouard M; Bouet V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction.
    Aguilar DD; Radzik LK; Schiffino FL; Folorunso OO; Zielinski MR; Coyle JT; Balu DT; McNally JM
    Sci Rep; 2021 Apr; 11(1):9031. PubMed ID: 33907230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.
    Labrie V; Wang W; Barger SW; Baker GB; Roder JC
    Genes Brain Behav; 2010 Feb; 9(1):11-25. PubMed ID: 19751394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
    Takagi S; Balu DT; Coyle JT
    Schizophr Res; 2015 Mar; 162(1-3):216-21. PubMed ID: 25592804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers.
    Benneyworth MA; Roseman AS; Basu AC; Coyle JT
    Neurosci Lett; 2011 Jan; 488(3):267-71. PubMed ID: 21094213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task.
    Ma L; Skoblenick K; Johnston K; Everling S
    J Neurosci; 2018 Mar; 38(10):2482-2494. PubMed ID: 29437929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.
    Balu DT; Li Y; Puhl MD; Benneyworth MA; Basu AC; Takagi S; Bolshakov VY; Coyle JT
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):E2400-9. PubMed ID: 23729812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization.
    Zhou X; Long JM; Geyer MA; Masliah E; Kelsoe JR; Wynshaw-Boris A; Chien KR
    Mol Psychiatry; 2005 Apr; 10(4):393-406. PubMed ID: 15558077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?
    Gandal MJ; Anderson RL; Billingslea EN; Carlson GC; Roberts TP; Siegel SJ
    Genes Brain Behav; 2012 Aug; 11(6):740-50. PubMed ID: 22726567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.
    Cadinu D; Grayson B; Podda G; Harte MK; Doostdar N; Neill JC
    Neuropharmacology; 2018 Nov; 142():41-62. PubMed ID: 29196183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of Npas4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia.
    Shepard R; Heslin K; Hagerdorn P; Coutellier L
    Transl Psychiatry; 2019 Feb; 9(1):99. PubMed ID: 30792384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
    Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW
    J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.